With this in mind , the current pilot study aimed to distinguish between Idiopathic Parkinson 's Disease ( iPD ) , other Parkinsonian syndromes ( non-iPD ) and healthy subjects , by a breath test that analyzes the exhaled volatile organic compounds using a highly sensitive nanoarray .